JAGSONPAL PHARMA TARGET 252
JAGSONPAL PHARMA under weekly breakout with long consolidation. Target 252
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.